• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Beneficial Impact of Apremilast on Palmoplantar Keratodermas.

作者信息

Nakajima Kimiko, Nakajima Riho, Morisaka Hiroyuki, Nakajima Hideki, Sano Shigetoshi

机构信息

Department of Dermatology , Kochi Medical School, Kochi University, 185-1 Kohasu, Okohcho, Nankoku, Kochi 783-8505, Japan. E-mail:

出版信息

Acta Derm Venereol. 2021 Apr 26;101(4):adv00437. doi: 10.2340/00015555-3805.

DOI:10.2340/00015555-3805
PMID:33880573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9364248/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ada/9364248/dded643383f6/ActaDV-101-4-799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ada/9364248/dded643383f6/ActaDV-101-4-799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ada/9364248/dded643383f6/ActaDV-101-4-799-g001.jpg

相似文献

1
Beneficial Impact of Apremilast on Palmoplantar Keratodermas.阿普斯特对掌跖角皮病的有益影响。
Acta Derm Venereol. 2021 Apr 26;101(4):adv00437. doi: 10.2340/00015555-3805.
2
Apremilast, beyond psoriasis as a therapeutic target.阿普司特，作为一种治疗靶点，其作用超出了银屑病范畴。
Med Clin (Barc). 2017 Jul 7;149(1):42-43. doi: 10.1016/j.medcli.2017.01.008. Epub 2017 Feb 24.
3
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.阿普米司特：用于银屑病和银屑病关节炎的治疗。
Drugs. 2017 Mar;77(4):459-472. doi: 10.1007/s40265-017-0709-1.
4
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.阿普米司特，一种口服磷酸二酯酶-4 抑制剂，治疗掌跖银屑病：来自 PSOR-005 Ⅱ期和 Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis（ESTEEM）Ⅲ期临床试验的汇总分析结果，该试验入组了中重度银屑病患者。
J Am Acad Dermatol. 2016 Jul;75(1):99-105. doi: 10.1016/j.jaad.2016.02.1164. Epub 2016 Mar 24.
5
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast.用阿普斯特成功治疗免疫检查点抑制剂诱导的银屑病。
Eur J Cancer. 2019 Mar;110:107-109. doi: 10.1016/j.ejca.2019.01.010. Epub 2019 Feb 18.
6
Synergistic cytokine effects as apremilast response predictors in patients with psoriasis.银屑病患者中协同细胞因子效应作为阿普斯特反应预测指标
J Allergy Clin Immunol. 2018 Sep;142(3):1010-1013.e6. doi: 10.1016/j.jaci.2018.05.039. Epub 2018 Jun 21.
7
Apremilast for a psoriasis patient with HIV and hepatitis C.阿普斯特用于一名合并感染艾滋病毒和丙型肝炎的银屑病患者。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e481-e482. doi: 10.1111/jdv.14301. Epub 2017 May 15.
8
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.阿普米司特治疗中重度掌跖银屑病：一项双盲、安慰剂对照、随机研究的结果。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):403-410. doi: 10.1111/jdv.14647. Epub 2017 Nov 15.
9
Apremilast for the management of moderate to severe plaque psoriasis.阿普米拉斯用于治疗中度至重度斑块状银屑病。
Expert Rev Clin Pharmacol. 2017 Apr;10(4):349-360. doi: 10.1080/17512433.2017.1293519. Epub 2017 Feb 17.
10
Effective treatment of nail psoriasis with apremilast: report of two cases and review of the literature.阿普司特治疗甲银屑病的有效性：两例报告及文献综述
Dermatol Online J. 2018 Sep 15;24(9):13030/qt27x34947.

引用本文的文献

1
Knuckle Pads Successfully Treated with 2% Crisaborole Ointment Combined with Triamcinolone Acetonide and Neomycin Plaster: A Case Report.2%克立硼罗软膏联合曲安奈德新霉素贴膏成功治疗指节垫：一例报告
Clin Cosmet Investig Dermatol. 2023 Jul 24;16:1893-1897. doi: 10.2147/CCID.S414268. eCollection 2023.

本文引用的文献

1
Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation.磷酸二酯酶-4抑制剂可降低人表皮角质形成细胞促炎介质的表达，且不依赖于细胞内cAMP升高。
J Dermatol Sci. 2020 Dec;100(3):230-233. doi: 10.1016/j.jdermsci.2020.09.014. Epub 2020 Oct 6.
2
Favorable response to apremilast in a patient with refractory psoriasis verrucosa.阿普司特治疗难治性疣状银屑病有效。
J Dermatol. 2019 Jun;46(6):544-547. doi: 10.1111/1346-8138.14877. Epub 2019 Apr 8.
3
Profiling Immune Expression to Consider Repurposing Therapeutics for the Ichthyoses.
分析免疫表达以考虑将治疗药物重新用于鱼鳞癣。
J Invest Dermatol. 2019 Mar;139(3):535-540. doi: 10.1016/j.jid.2018.08.027. Epub 2019 Jan 19.
4
Biologic therapy targeting IL-17 ameliorates a case of congenital ichthyosiform cornification disorder.靶向白细胞介素-17的生物疗法改善了一例先天性鱼鳞病样角化障碍病例。
J Dtsch Dermatol Ges. 2019 Jan;17(1):70-72. doi: 10.1111/ddg.13716. Epub 2018 Dec 3.
5
Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.一例毛发红糠疹在阻断白细胞介素-17A 后进展为泛发性红皮病，但在阻断白细胞介素-12/23 p40 后有所改善。
J Dermatol. 2019 Jan;46(1):70-72. doi: 10.1111/1346-8138.14709. Epub 2018 Dec 3.
6
Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.阿普米司特治疗银屑病临床疗效的潜在机制
J Drugs Dermatol. 2018 Aug 1;17(8):835-840.
7
A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor Apremilast.一例用磷酸二酯酶-4抑制剂阿普斯特成功治疗的红皮病型毛发红糠疹病例。
Acta Derm Venereol. 2018 Nov 5;98(10):975-976. doi: 10.2340/00015555-2995.
8
Ichthyosis molecular fingerprinting shows profound T17 skewing and a unique barrier genomic signature.鱼鳞病分子指纹图谱显示出明显的 T17 偏倚和独特的屏障基因组特征。
J Allergy Clin Immunol. 2019 Feb;143(2):604-618. doi: 10.1016/j.jaci.2018.03.021. Epub 2018 May 24.
9
Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis.阿普米司特治疗中重度斑块型银屑病的真实世界疗效和安全性数据。
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1173-1179. doi: 10.1111/jdv.14832. Epub 2018 Mar 30.
10
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.阿普米司特治疗中重度掌跖银屑病：一项双盲、安慰剂对照、随机研究的结果。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):403-410. doi: 10.1111/jdv.14647. Epub 2017 Nov 15.